Church & Dwight to Sell VitaFusion and L'il Critters Brands
Business Wire (Tue, 9-Dec 4:30 PM ET)
Church & Dwight Delivers Strong Q3 on Cash Flow, Brand Innovation, and International Momentum
Market Chameleon (Fri, 31-Oct 4:23 AM ET)
Church & Dwight Reports Q3 2025 Results
Business Wire (Fri, 31-Oct 6:55 AM ET)
Church & Dwight Co., Inc. Declares 499th Regular Quarterly Dividend
Business Wire (Mon, 27-Oct 4:13 PM ET)
LoopMe Expands Strategic Advisory Board to Power Agile Innovation
Business Wire (Wed, 1-Oct 10:09 AM ET)
Church & Dwight to Webcast Discussion of Third Quarter 2025 Earnings Results on October 31
Business Wire (Tue, 30-Sep 10:53 AM ET)
Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its brands also include Batiste, OxiClean, Vitafusion, Hero, and TheraBreath, which, together with Arm & Hammer, account for around 70% of its annual sales and profits. Most recently, the firm added Touchland and its hand sanitizer business to its fold. Even as it works to expand its product reach, Church & Dwight still derives around 80% of its sales from its home market in the US.
Church & Dwight Company trades on the NYSE stock market under the symbol CHD.
As of December 31, 2025, CHD stock price declined to $83.85 with 918,144 million shares trading.
CHD has a beta of 0.09, meaning it tends to be less sensitive to market movements. CHD has a correlation of 0.01 to the broad based SPY ETF.
CHD has a market cap of $20.13 billion. This is considered a Large Cap stock.
Last quarter Church & Dwight Company reported $2 billion in Revenue and $.81 earnings per share. This beat revenue expectation by $52 million and exceeded earnings estimates by $.08.
In the last 3 years, CHD traded as high as $116.46 and as low as $78.63.
The top ETF exchange traded funds that CHD belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
CHD has underperformed the market in the last year with a price return of -18.7% while the SPY ETF gained +17.2%. CHD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -4.0% and -0.8%, respectively, while the SPY returned +2.7% and +0.7%, respectively.
CHD support price is $83.36 and resistance is $85.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CHD shares will trade within this expected range on the day.
